The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) ...

Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...

Compared with standard AUD medications, the use of semaglutide and liraglutide was linked to a lower risk for alcohol use ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.

TennCare is federally required to cover GLP-1 drugs; of the $118M in the cost increase request, more than $76 million would ...

Natixis Advisors LLC boosted its holdings in Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 40.4% in the third ...

GLP-1RA dispensing has increased from 2022 and 2023, whereas metabolic bariatric surgery has decreased among individuals with obesity.

A multistate model that enables real-time risk recalculations may help improve risk stratification for prediction of ...